Description: Female BALB/c (n=75) mice were challenged with varying doses of USA300 NRS384 via the intravenous (IV) route.
Description: Female BALB/c (n=190) mice were challenged with varying doses of USA300 NRS384 via the intraperitoneal (IP) route.
Description: Female BALB/c (n=30) mice were challenged with 1x LD90 of USA300 NRS384 via the intraperitoneal (IP) route. All animals were challenged on day 0 and received treatment via the IP route twice daily for five days.
For Product Information,
Orders & Technical Support
products@integratedbiotherapeutics.com
For Services
services@ibtbioservices.com
